Hello,
The SRA article in NAR (http://www.oxfordjournals.org/nar/database/summary/1456) states:
It is to be noted that data requiring authorized access, such as human genome sequenced under ethical consent agreements, should be submitted to the database of phenotypes and genotypes at NCBI (dbGaP, http://www.ncbi.nlm.nih.gov/gap) or to the European Genome-phenome Archive at EBI (EGA, http://www.ebi.ac.uk/ega). Data submitted to dbGaP or EGA is not part of the public SRA. However, summary level metadata is made available through SRA.
Our questions are
- do you have a sense of how comprehensive the inclusion of metadata for clinical datasets in the SRA is? That is to say, does the SRA contain metadata on all of the NGS datasets in dbGAP and EGA?
- And related to this, are the clinical datasets in dbGAP and EGA just from publicly funded studies?
Thank You for your help in advance.
The SRA article in NAR (http://www.oxfordjournals.org/nar/database/summary/1456) states:
It is to be noted that data requiring authorized access, such as human genome sequenced under ethical consent agreements, should be submitted to the database of phenotypes and genotypes at NCBI (dbGaP, http://www.ncbi.nlm.nih.gov/gap) or to the European Genome-phenome Archive at EBI (EGA, http://www.ebi.ac.uk/ega). Data submitted to dbGaP or EGA is not part of the public SRA. However, summary level metadata is made available through SRA.
Our questions are
- do you have a sense of how comprehensive the inclusion of metadata for clinical datasets in the SRA is? That is to say, does the SRA contain metadata on all of the NGS datasets in dbGAP and EGA?
- And related to this, are the clinical datasets in dbGAP and EGA just from publicly funded studies?
Thank You for your help in advance.